The Rs 800 crore Elder Pharmaceuticals Limited and maker of brands like the calcium supplement ShelCal, expects to launch about 35 new products in the next 30 months. The products would be in therapeutic areas like female healthcare, osteoporosis, dermatology, pain management, cardiology, nutraceuticals, wound care and vitamin supplements, the company said. The products would be through a combination of in-licensed and owned products although the larger focus will be on self-researched products.

Elder Pharma is targeting a turnover of Rs 1500 crore by 2013 and has research centre at Navi Mumbai, staffed by about 100 scientists.

comment COMMENT NOW